Screener
Intellia Therapeutics NTLA Common Stock
Common Stock at other companies
Other financials
Where this comes from
Reported directly by Intellia Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:CommonStockValue.
The source filing: Intellia Therapeutics’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 4:05 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-337952
| Line item | June 30,2026 | December 31,2025 |
|---|---|---|
| Total liabilities | 129,458 | 170,733 |
| Commitments and contingencies (Note 6) | ||
| Stockholders’ equity: | ||
| Common stock, $0.0001 par value; 240,000,000 shares authorized at June 30, 2026 and December 31, 2025; 140,018,200 and 116,317,060 shares issued and outstanding at June 30, 2026 and December 31, 2025, respectively | 14 | 12 |
| Additional paid-in capital | 3,521,681 | 3,260,444 |
| Accumulated other comprehensive (loss) income | (1,030) | 1,032 |
| Accumulated deficit | (2,792,959) | (2,590,094) |
| Total stockholders’ equity | 727,706 | 671,394 |
Item 1. Financial Statements
FAQ
- What is Intellia Therapeutics's common stock?
- Intellia Therapeutics (NTLA) reported common stock of $14K in Q2 2026.
- How has Intellia Therapeutics's common stock changed year-over-year?
- Intellia Therapeutics's common stock increased by 40.0% year-over-year, from $10K to $14K.
- What is the long-term trend for Intellia Therapeutics's common stock?
- Over 5 years (2020 to 2025), Intellia Therapeutics's common stock has grown at a 11.4% compound annual growth rate (CAGR), from $7K to $12K.
- What does common stock mean?
- The par value of all common shares issued and outstanding, typically a nominal amount ($0.01 or $0.001 per share).
Ask your AI about Intellia Therapeutics's common stock.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude